MarketInOut Stock Screener Log In | Sign Up
 

YD Bio Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
YD Bio Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization408.7 mln
Float14.08 mln
Earnings Date11/30/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

8 / 100
Severely lagging

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-1,393%
Severely loss-making

ROE

-445
Deeply negative

ROA

-38.42
Deeply negative

Business Description

YD Bio Limited is a Taiwan-based medical research company working to improve how serious diseases are diagnosed and treated. Its core work centers on detecting cancer through blood tests, while also exploring new therapies built on stem cells and exosomes. These efforts aim to address conditions where patients currently have few or no effective treatment options.

Key Fundamentals

EPS-0.04
ROE-445
RPS0.02
ROIC-7.33
ROA-38.42
EBITDA, mln-2.99
EV / EBITDA-182
EV / EBIT-182
Revenue, mln0.60
EV / Revenue911

Quote Details

Last 4.95
Change 0.71 (16.75%)
Open 4.28
Volume 105,091
Turnover 520,200
Average Volume 229,440

Financial Ratios

Pre-Tax Profit Margin-1,393
Current Ratio0.02
Price / Book91.59
Debt / Equity0.00
Price / Sales852

Financial Strength

Piotroski F-Score 4 / 9
Short Ratio0.26
Short % of Float1.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.39% 4 / 100   
1 Month 3.77% 86 / 100   
2 Months 118% 99 / 100   
6 Months -9.34% 36 / 100   
1 Year -71.73% 11 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog